Cardiology News

Preeclampsia was associated with a significantly increased venous thromboembolism risk during pregnancy and beyond 6 weeks postpartum, according to an observational cohort study published in JAMA Network Open.

Initiating treatment with thiazide diuretics was linked to increased incidences of low blood sodium below 130 mmol/L, also known as hyponatremia, compared with non-thiazide antihypertensive drugs, according to researchers.

Global cardiovascular mortality increased through 2022, with BP remaining the largest contributor to CVD worldwide, according to an almanac-style report published in the Journal of the American College of Cardiology.

Findings from two cardiovascular outcome trials revealed that targeting obesity could become a major focus for treating cardiovascular disease and heart failure with preserved ejection fraction in the future, according to a speaker.

Promising new devices and emerging drug classes may improve BP control for some patients with difficult-to-treat hypertension, but clinicians must first address the structural inequities that impact access to care, according to a speaker.

Small HDL particles play a significant role in the prevention of Alzheimer’s disease, and an inherited gene present in one in four people hinders its production in the brain, increasing risk for cognitive decline, a speaker reported.

Composite CVD risk factor control for U.S. adults with type 2 diabetes remains poor, but clinicians can use newer risk scores to better assess patients and prevent CV events with targeted therapies, according to a speaker.

SAN DIEGO — Patients with systemic lupus erythematosus who are positive for antiphospholipid antibodies have a greater risk for future atherosclerotic cardiovascular disease, according to data presented at ACR Convergence 2023.

A speaker reported that improved differentiation of resistant vs. refractory hypertension is essential in choosing optimal antihypertensive treatment, as the two represent different disease states of elevated blood pressure.

Compared with men, women with prediabetes may benefit from earlier intervention to prevent cardiovascular disease, according to a presenter at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease Conference.